A new general glucose homeostatic model using a proportional-integral-derivative controller

The glucose-insulin system is a challenging process to model due to the feedback mechanisms present, hence the implementation of a model-based approach to the system is an on-going and challenging research area. A new approach is proposed here which provides an effective way of characterising glycaemic regulation. The resulting model is built on the premise that there are three phases of insulin secretion, similar to those seen in a proportional-integral-derivative (PID) type controller used in engineering control problems. The model relates these three phases to a biological understanding of the system, as well as the logical premise that the homeostatic mechanisms will maintain very tight control of the system. It includes states for insulin, glucose, insulin action and a state to simulate an integral function of glucose. Structural identifiability analysis was performed on the model to determine whether a unique set of parameter values could be identified from the available observations, which should permit meaningful conclusions to be drawn from parameter estimation. Although two parameters--glucose production rate and the proportional control coefficient--were found to be unidentifiable, the former is not a concern as this is known to be impossible to measure without a tracer experiment, and the latter can be easily estimated from other means. Subsequent parameter estimation using Intravenous Glucose Tolerance Test (IVGTT) and hyperglycaemic clamp data was performed and subsequent model simulations have shown good agreement with respect to these real data.

[1]  John J Mastrototaro,et al.  Metabolic modelling and the closed-loop insulin delivery problem. , 2006, Diabetes research and clinical practice.

[2]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[3]  Ovide Arino,et al.  Mathematical modelling of the intravenous glucose tolerance test , 2000, Journal of mathematical biology.

[4]  B. Kasiske,et al.  The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. , 1992, Hypertension.

[5]  Christopher E. Hann,et al.  Monte Carlo analysis of a new model-based method for insulin sensitivity testing , 2008, Comput. Methods Programs Biomed..

[6]  Haiying Cheng,et al.  Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. , 2002, Diabetes.

[7]  A Mari,et al.  Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach. , 2000, American journal of physiology. Endocrinology and metabolism.

[8]  R N Bergman,et al.  Accurate measurement of endogenous insulin secretion does not require separate assessment of C-peptide kinetics. , 2000, Diabetes.

[9]  D Langin Diabetes, insulin secretion, and the pancreatic beta-cell mitochondrion. , 2001, The New England journal of medicine.

[10]  K R Godfrey,et al.  Global identifiability of the parameters of nonlinear systems with specified inputs: a comparison of methods. , 1990, Mathematical biosciences.

[11]  V. Bolie,et al.  Coefficients of normal blood glucose regulation. , 1961, Journal of applied physiology.

[12]  M. Müller,et al.  Glucose production measured by tracer and balance data in conscious miniature pig. , 1983, The American journal of physiology.

[13]  F. Kaufman,et al.  A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. , 2001, Diabetes care.

[14]  M. T. Vester,et al.  Control design for an industrial distillation column , 1993 .

[15]  S E Kahn,et al.  The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. , 1996, The Journal of clinical investigation.

[16]  Ronald Gieschke,et al.  An Integrated Model for Glucose and Insulin Regulation in Healthy Volunteers and Type 2 Diabetic Patients Following Intravenous Glucose Provocations , 2007, Journal of clinical pharmacology.

[17]  M. Hochberg,et al.  Control engineering , 1991, Nature.

[18]  Neil D. Evans,et al.  Structural identifiability analysis via symmetries of differential equations , 2009, Autom..

[19]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[20]  R. Miura,et al.  A Model of β -Cell Mass, Insulin, and Glucose Kinetics: Pathways to Diabetes , 2000 .

[21]  G. Steil,et al.  Closed-loop insulin delivery-the path to physiological glucose control. , 2004, Advanced drug delivery reviews.

[22]  Geoffrey M Shaw,et al.  Derivative weighted active insulin control modelling and clinical trials for ICU patients. , 2004, Medical engineering & physics.

[23]  R. Miura,et al.  A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes. , 2000, Journal of theoretical biology.

[24]  H. Landahl,et al.  Comparison of storage- and signal-limited models of pancreatic insulin secretion. , 1980, The American journal of physiology.

[25]  G M Steil,et al.  Modeling insulin action for development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.

[26]  J. Geoffrey Chase,et al.  DISTq: An Iterative Analysis of Glucose Data for Low-Cost, Real-Time and Accurate Estimation of Insulin Sensitivity , 2009, The open medical informatics journal.

[27]  M Ibbini A PI-fuzzy logic controller for the regulation of blood glucose level in diabetic patients , 2006, Journal of medical engineering & technology.

[28]  A. Valerio,et al.  A Circulatory Model for the Estimation of Insulin Sensitivity , 1997 .

[29]  William J Jusko,et al.  Modeling the metabolic effects of terbutaline in β2‐adrenergic receptor diplotypes , 2004, Clinical pharmacology and therapeutics.

[30]  R N Bergman,et al.  MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. , 1986, Computer methods and programs in biomedicine.

[31]  Bruce Buckingham,et al.  Glucose control in pediatric intensive care unit patients using an insulin-glucose algorithm. , 2007, Diabetes technology & therapeutics.

[32]  Dale E. Seborg,et al.  An Improved PID Switching Control Strategy for Type 1 Diabetes , 2008, IEEE Transactions on Biomedical Engineering.